MarketPR

Sunshine Biopharma closes $6 million public offering

10/10/2026

(NASDAQ: SBFM) completed a previously announced public offering, securing approximately $6.0 million in gross proceeds before deducting placement agent fees and other expenses.

The transaction was executed on a reasonable best efforts basis and closed on October 9, 2026. The offering comprised 10,909,082 Common Units sold at a public offering price of $0.55 per unit.

Each unit consists of one share of Common Stock or one Pre-Funded Warrant, paired with two Series D Warrants.

Holders may exercise the Series D Warrants immediately to purchase one share of Common Stock per warrant at an initial exercise price of $0.66.

Keep reading

Read the full story

Open on MarketPR